141 related articles for article (PubMed ID: 10386679)
1. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis.
Smith RW; Scott PA; Grant RJ; Chudnofsky CR; Frederiksen SM
Acad Emerg Med; 1999 Jun; 6(6):618-25. PubMed ID: 10386679
[TBL] [Abstract][Full Text] [Related]
2. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
[TBL] [Abstract][Full Text] [Related]
4. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
5. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.
Brown DL; Barsan WG; Lisabeth LD; Gallery ME; Morgenstern LB
Ann Emerg Med; 2005 Jul; 46(1):56-60. PubMed ID: 15988427
[TBL] [Abstract][Full Text] [Related]
6. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
[TBL] [Abstract][Full Text] [Related]
7. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
8. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
9. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
Vaishnav AG; Pettigrew LC; Ryan S
Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
[TBL] [Abstract][Full Text] [Related]
10. Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.
Asaithambi G; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e42-5. PubMed ID: 22572162
[TBL] [Abstract][Full Text] [Related]
11. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
[TBL] [Abstract][Full Text] [Related]
12. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
Tilley BC; Lyden PD; Brott TG; Lu M; Levine SR; Welch KM
Arch Neurol; 1997 Dec; 54(12):1466-74. PubMed ID: 9400355
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the implementation of a 24-hr stroke thrombolysis emergency treatment for patients with acute ischaemic stroke.
Zhao J; Li X; Liang Y; Zhao L; Zhang X; Liu Y
J Clin Nurs; 2018 May; 27(9-10):2161-2167. PubMed ID: 29345016
[TBL] [Abstract][Full Text] [Related]
14. Stroke thrombolysis given by emergency physicians cuts in-hospital delays significantly immediately after implementing a new treatment protocol.
Heikkilä I; Kuusisto H; Stolberg A; Palomäki A
Scand J Trauma Resusc Emerg Med; 2016 Apr; 24():46. PubMed ID: 27067664
[TBL] [Abstract][Full Text] [Related]
15. Hematoma expansion in experimental intracerebral hemorrhage is not altered by peracute treatment with recombinant tissue plasminogen activator.
Pfeilschifter W; Kashefiolasl S; Lauer A; Steinmetz H; Foerch C
Neuroscience; 2013 Oct; 250():181-8. PubMed ID: 23856067
[TBL] [Abstract][Full Text] [Related]
16. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
Yan X; Hu HT; Liu S; Sun YH; Gao X
Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
18. Hyperacute stroke therapy with tissue plasminogen activator.
Alberts MJ
Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
Williams JM; Navin TJ; Jude MR; Levi CR
Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
[TBL] [Abstract][Full Text] [Related]
20. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older.
Zacharatos H; Hassan AE; Vazquez G; Hussein HM; Rodriguez GJ; Suri MF; Lakshminarayan K; Ezzeddine MA; Qureshi AI
Am J Emerg Med; 2012 Jan; 30(1):158-64. PubMed ID: 21247724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
